Item 2 Issuer Principal Place of Business and Contact Information
787 SEVENTH AVENUE, 48TH FLOOR
NEW YORK, NY 10019
Phone Number:
subscription required
Item 3. Related Persons
Name
MICHAEL WEISS
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
SEAN POWER
Address
subscription required
Relationship(s)
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
NEIL HERSKOWITZ
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
NO REVENUES
Item 6. Federal Exemptions and Exclusions Claimed
06
Item 7. Type of Filing
Amendment
Date of First Sale in this Offering:
12/30/2011
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Equity
Option, Warrant or Other Right to Acquire Another Security
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
50000
Item 12. Sales Compensation
Recipient
NONE
Recipient CRD Number
NONE
(Associated) Broker or Dealer)
NATIONAL SECURITIES CORPORATION
(Associated) Broker or Dealer CRD Number
7569
Address
1001 FOURTH AVENUE, SUITE 3750
SEATTLE, WA 98154
States of Solicitation
AL
AZ
AR
CA
CO
CT
DE
DC
FL
GA
HI
ID
IL
IN
IA
KS
KY
LA
MD
MA
MI
MN
MS
MO
NE
NV
NH
NJ
NM
NY
NC
OH
OK
OR
PA
RI
SC
TN
TX
UT
VT
VA
WA
WV
WI
Item 13. Offering and Sales Amounts
Total Offering Amount
25000000
Total Amount Sold
25000000
Total Remaining to be Sold
0
Clarification of Response
THE OFFERING INCLUDES SECURITIES TO BE ACQUIRED UPON THE EXERCISE OR EXCHANGE OF OTHER SECURITIES.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
416
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
2500000.0 Is an estimate
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
2412730.0 Is an estimate
Clarification of Response
Signature and Submission
Notice has been signed on behalf by the undersigned duly authorized person